DelveInsight’s “Cataplexy Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Cataplexy, historical and forecasted epidemiology as well as the Cataplexy market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Cataplexy Overview
Cataplexy is a sudden and transient episode of muscle weakness accompanied by full conscious awareness, typically triggered by emotions such as laughing, crying, or terror.[1] Cataplexy affects approximately 70% of people who have narcolepsy, and is caused by the autoimmune destruction of hypothalamic neurons that produce the neuropeptide hypocretin (also called orexin), which regulates arousal and has a role in the stabilization of the transition between wake and sleep states.] Cataplexy without narcolepsy is rare and the cause is unknown.
The term cataplexy originates from the Greek κατά (kata, meaning “down”), and πλῆξις (plēxis, meaning “strike”), and it was first used around 1880 in German physiology literature to describe the phenomenon of tonic immobility also known as “playing possum” (in reference to the opossum’s behavior of feigning death when threatened). In the same year, the French neuropsychiatrist Jean-Baptiste Gélineau coined the term ‘narcolepsy’ and published some clinical reports that contain details about two patients who have similar conditions as the narcoleptic cases nowadays. Nevertheless, the onset reported by him was in adulthood as compared to the nowadays cases reported in childhood and adolescence. Even if he preferred the term ‘astasia’ instead of ‘cataplexy’ the case described by him remained iconic for the full narcoleptic syndrome
The Report Covers the Cataplexy Epidemiology Segmented by –
Cataplexy prevalent cases
Cataplexy incident cases
Cataplexy diagnosed cases
Cataplexy treatment cases
Cataplexy Market Outlook
The Cataplexy market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Cataplexy market trends by analyzing the impact of current Cataplexy therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Cataplexy market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Cataplexy market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Cataplexy market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Cataplexy Market include:
Axome Therapeutics
Suven Therapeutics
Takeda
Avel Therapeutics
And many others
Cataplexy Therapies Covered in the Report:
SUVN-G3031
AXS-12 (reboxetine)
FT218
TAK-861
Table of Contents
Key Insights
Report Introduction
Executive Summary of Cataplexy Market
Cataplexy Background and Overview
Cataplexy Epidemiology and patient population
Cataplexy Market Emerging Therapies
Cataplexy Market Cancer Market Outlook
Market Access and Reimbursement of Therapies
Appendix
Market Report Methodology
DelveInsight Capabilities
Disclaimer
About DelveInsight
Learn more about detailed report offerings @ Cataplexy Market Outlook
Trending Reports by DelveInsight
Adalimumab Biosimilar Market
Arbovirus Infection Market
Artificial Pancreas Device System Market
Dental Equipment Market
Gluten Sensitivity Market
Hypothyroidism Market
Inflammatory Bowel Disease Market
Mayus Kinase Jak Inhibitors Market
Mild Dry Eye Market
Mucopolysaccharidosis Market
Oncolytic Virus Cancer Therapy Market
Pyoderma Gangrenosum Market
Transdermal Drug Delivery Devices Market
Intrathecal Pumps Market
Hedgehog Pathway Inhibitors Market
Yellow Fever Market
Laryngeal Cancer Market
Female Infertility Market
Gender Dysphoria Market
Cataplexy Market
Spain Healthcare Outlook Market
Malignant Fibrous Histiocytoma Market
Related Reports
Cataplexy Pipeline Insight
DelveInsight’s, “Cataplexy – Pipeline Insights, 2023,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Cataplexy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting/due-diligence-services